| Literature DB >> 25129482 |
Tomasz Targowski1, Sylwia Chelstowska, Tadeusz Plusa.
Abstract
OBJECTIVES: We conducted a study on usefulness of the tuberculin skin test (TST) and the Quantiferon-TB Gold IT (QFT) tests as predictors of radiological changes after contact with tuberculosis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25129482 PMCID: PMC4237935 DOI: 10.1007/s00408-014-9637-y
Source DB: PubMed Journal: Lung ISSN: 0341-2040 Impact factor: 2.584
Characteristics of the subgroups with and without silent chest X-ray findings
| Characteristics | Participants with pulmonary lesions | Participants without pulmonary lesions |
|---|---|---|
| Age mean (SD) yr | 46.6 (11.3) | 42.7 (10.8)* |
| Time from TB contact, mean (SD) yr | 17.0 (10.8) | 12.2 (8.7)** |
| Circle of contact, | ||
| Inner | 9 (10.8) | 12 (14.5) |
| Middle | 5 (6.0) | 28 (33.7) |
| Outer | 4 (4.8) | 25 (30.1) |
| TST ≥10 mm, | 15 (18.1) | 57 (68.7) |
| TST <10 mm, | 3 (3.6) | 8 (9.6) |
| TST ≥15 mm, | 11 (13.3) | 36 (43.4) |
| TST <15 mm, | 7 (8.4) | 29 (34.9) |
| QFT positive, | 13 (15.7) | 14 (16.9) |
| QFT negative, | 5 (6.0) | 51 (61.4) |
| QFT positive and TST ≥10, | 10 (12.1) | 13 (15.7) |
| QFT negative and TST <10 mm, | 8 (9.6) | 52 (62.3) |
| QFT positive and TST ≥ 15 mm, | 11 (13.3) | 35 (42.2) |
| QFT negative and TST < 15 mm, | 7 (8.4) | 30 (36.1) |
* p value = 0.2; ** p value = 0.052
Usefulness of QFT and TST in prediction of clinically silent chest X-ray opacities characteristic for tuberculosis
| TST ≥ 10 mm | TST ≥15 mm | QFT positive | QFT positive and TST ≥10 mm | QFT positive and TST ≥15 mm | |
|---|---|---|---|---|---|
| Sensitivity % | 83.3 (60.8–94.2) | 61.1 (38.6–79.7) | 72.9 (49.1–87.5) | 55.6 (33.7–75.4) | 61.1 (38.6–79.7) |
| Specificity % | 12.3 (6.4–22.5) | 44.6 (33.2–56.7) | 78.5 (67.0–86.7) | 80.0 (68.7–87.9) | 46.2 (34.6–58.2) |
| Accuracy % | 28.9 (20.3–39.4) | 48.2 (37.8–58.8) | 77.1 (67.0–84.8) | 74.7 (64.4–82.8) | 49.4 (38.9–59.9) |
| Negative predictive value % | 72.7 (43.4–90.3) | 80.1 (65.0–90,3) | 91.1 (80.7–96.1) | 86.7 (75.8–93.1) | 81.1 (65.8–90.5) |
| Positive predictive value % | 20.8 (13.1–31.2) | 23.4 (13.6–37.2) | 48.2 (30.7–66.0) | 43.5 (25.6–63.2) | 23.9 (13.9–37.9) |
| Positive likelihood ratio LR+ | 1.0 (0.8–1.2) | 1.1 (0.7–1.7) | 3.4 (1.9–5.8) | 2.8 (1.5–55.3) | 1.1 (0.7–1.8) |
| Negative likelihood ratio LR- | 1.4 (0.4–4.6) | 0.9 (4.6–16.5) | 0.3 (0.2–0.7) | 0.6 (0.3–0.9) | 0.8 (0.5–1.6) |
QFT, TST, and chest X-ray results in relation to the degree of exposure
|
|
|
|
| ||
|---|---|---|---|---|---|
|
| |||||
| Yes | 13 (61.9 %) | 8 (24.2 %) | 6 (20.7 %) | 27 (32.5 %) | Circle 1 vs. 2; |
| No | 8 (38.1 %) | 25 (75.8 %) | 23 (79.3 %) | 56 (67.5 %) | Circle 1 vs. 3; Circle 2 vs. 3; |
| TST positive | |||||
| Yes | 20 (95.2 %) | 29 (87.9 %) | 23 (79.3 %) | 72 (86.7 %) | Circle 1 vs. 2; |
| No | 1 (4.8 %) | 4 (12.1 %) | 6 (20.7 %) | 11 (13.3 %) | Circle 1 vs. 3; Circle 2 vs. 3; |
| QFT positive and TST ≥10 mm | |||||
| Yes | 12 (57.1 %) | 8 (24.2 %) | 3 (10.3 %) | 23 (27.7 %) | Circle 1 vs. 2; |
| No | 9 (42.9 %) | 25 (75.8 %) | 26 (89.7 %) | 60 (72.3 %) | Circle 1 vs. 3; Circle 2 vs. 3; |
| Chest X-ray findings | |||||
| Present | 9 (42.9 %) | 5 (15.1 %) | 4 (13.8 %) | 18 (21.7 %) | Circle 1 vs. 2; |
| Absent | 12 (57.1 %) | 28 (84.9 %) | 25 (86.2 %) | 65 (78.3 %) | Circle 1 vs. 3; Circle 2 vs. 3; |
* Statistically significant p value
Results of the log-linear analysis for predictors of presence of late clinically silent pulmonary opacities (logistic regression model; χ 2 = 18.7, overall p = 0.0009)
| Variable | Odds ratio | 95 % CI |
|
|---|---|---|---|
| Circle of contact | |||
| 1st vs. 2nd and 3rd | 0.5 | 0.2–1.3 | 0.1 |
| QFT positive | |||
| Yes vs. no | 8.3 | 2.5–27.8 | 0.005 |
| QFT positive and TST ≥10 mm | |||
| Yes vs. no | 0.3 | 0.07–1.2 | 0.08 |
| Time from TB contact | 1.04 | 0.9–1.1 | 0.2 |